Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Viatris Inc

NASDAQ: VTRS · Life Sciences · 4 alerts · CIK 1792044

Viatris Inc stories on ALFA USA NewsRead the news →
Share price
$20.74Close, Nov 16
Market cap
$23.8B
Shares outstanding
1.15BLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Viatris Inc filings on SEC EDGAR ↗

9:45 AM ET 8-K
M&A Deal

Viatris Signs $1.69B M&A Deal with Pacira BioSciences, Inc.

Viatris Inc. has completed its acquisition of Pacira BioSciences, Inc. for approximately $1.69 billion in cash. The transaction was executed via a tender offer for $36.50 per share followed by a merger, establishing Viatris as a leader in non-opioid pain management.

Value
$1.69B
Counterparty
Pacira BioSciences, Inc.

“Today marks an important milestone in the execution of our strategy to strengthen our U.S. innovative medicines business. With Pacira now part of Viatris, we are bringing together complementary portfolios, capabilities and expertise to establish a leadership position in non-opioid pain management. We are excited to welcome our new Pacira colleagues as we create new opportunities to make a meaningful difference for patients and accelerate our path to sustained revenue and earnings growth.”

Scott A. Smith, CEO of Viatris

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.